Mr. Chou continued, "We are glad to see that Chinese hi-tech companies have invested a lot of effort into enhancing their competitiveness despite external challenges. Looking forward, most hi-tech companies will continue on a recovery track from the financial crisis. We are pleased that many CEOs have expressed confidence in the future market and have said they will invest more in the research and development (R&D) of new products and technologies."
This is the fifth anniversary of the Deloitte Technology Fast 50 China Program since this global program was introduced in China in 2005. This program was designed to showcase the countries' emerging innovative companies with great growth potential in the Telecom, Media, and Hi-Tech sectors. Its annual Top lists have become an influential bellwether for global financial and investment circles. For the 2009 Deloitte Technology Fast 50 China Program, the Top 5 companies achieved an electrifying three-year average revenue growth ranging from 1,771.02% to 29,576.86%. The Top 50 China Winning Companies will be entered into the 2009 Deloitte Technology Fast 500 Asia & Pacific Program.
About Shanghai ChemPartner
Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of
the leading contract research organizations, providing medicinal chemistry,
discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical
development, formulation and contract manufacturing services to over 120
pharmaceutical and biotech companies across the globe. ChemPartner currently
has a team of over 1000 scientists including nearly 100 senior scientific
leaders with extensive industry experiences gained fro
|SOURCE Shanghai ChemPartner Company Ltd.|
Copyright©2009 PR Newswire.
All rights reserved